Dengue-3 virus genomic differences that correlate with in vitro phenotype on a human cell line but not with disease severity

Microbes and Infection

Volumn 9, Issue 1, 2007, Pages 63-69

  Roche, Claudine ^a   Cassar, Olivier ^a   Laille, Manola ^a   Murgue, Bernadette ^a  

^a INSTITUT LOUIS MALARDÉ   (French Polynesia)

Author keywords

Dengue; Dengue hemorrhagic fever; French Polynesia; Molecular sequencing data; Pathogenicity; Severity; Viral genome

Indexed keywords

NUCLEOTIDE;

3' UNTRANSLATED REGION; AMINO ACID SUBSTITUTION; ARTICLE; CELL GROWTH; COMPARATIVE STUDY; DENGUE; DENGUE VIRUS; DENGUE VIRUS 3; DISEASE SEVERITY; EPIDEMIC; FRENCH POLYNESIA; GENE INSERTION; GENE SEQUENCE; GLYCOSYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS ISOLATION;

AMINO ACID SEQUENCE; CONSENSUS SEQUENCE; DENGUE; DENGUE VIRUS; GENOME, VIRAL; HUMANS; K562 CELLS; PHENOTYPE; PHYLOGENY; SEVERITY OF ILLNESS INDEX;

DENGUE VIRUS; DENGUE VIRUS TYPE 3;

EID: 33846409096     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.10.010     Document Type: Article

References (31)

1. Modis Y., Ogata S., Clements D., and Harrison S.C. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 6986-6991
2. Harris E., Videa E., Perez L., Sandoval E., Tellez Y., Perez M.L., Cuadra R., Rocha J., Idiaquez W., Alonso R.E., Delgado M.A., Campo L.A., Acevedo F., Gonzalez A., Amador J.J., and Balmaseda A. Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am. J. Trop. Med. Hyg. 63 (2000) 5-11
3. Phuong C.X., Nhan N.T., Kneen R., Thuy P.T., van Thien C., Nga N.T., Thuy T.T., Solomon T., Stepniewska K., and Wills B. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful?. Am. J. Trop. Med. Hyg. 70 (2004) 172-179
4. Lum L.C.S., Lam S.K., Choy Y.S., George R., and Harun F. Dengue encephalitis: a true entity?. Am. J. Trop. Med. Hyg. 54 (1996) 256-259
5. Angibaud G., Luaute J., Laille M., and Gaultier C. Brain involvement in dengue fever. J Clin. Neurosci. 8 (2001) 63-65
6. Couvelard A., Marianneau P., Bedel C., Drouet M.T., Vachon F., Henin D., and Deubel V. Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis. Hum. Pathol. 30 (1999) 1106-1110
7. Murgue B., Deparis X., Chungue E., Cassar O., and Roche C. Dengue: an evaluation of dengue severity in French Polynesia based on an analysis of 403 laboratory-confirmed cases. Trop. Med. Int. Health 4 (1999) 765-773
8. Souza L.J., Alves J.G., Nogueira R.M., Gicovate Neto C., Bastos D.A., Siqueira E.W., Souto Filho J.T., Cezario Tde A., Soares C.E., and Carneiro Rda C. Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1,585 cases. Braz. J. Infect. Dis. 8 (2004) 156-163
9. Kabra S.K., Jain Y., Singhal T., and Ratageri V.H. Dengue hemorrhagic fever: clinical manifestations and management. Indian J. Pediatr. 66 (1999) 93-101
10. Wichmann O., Hongsiriwon S., Bowonwatanuwong C., Chotivanich K., Sukthana Y., and Pukrittayakamee S. Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand. Trop. Med. Int. Health 9 (2004) 1022-1029
11. Rosen L. Disease exacerbation caused by sequential dengue infections: myth or reality?. Rev. Infect. Dis. 11 (1989) S840-S842
12. Murgue B., Cassar O., Guigon M., and Chungue E. Dengue virus inhibits human hematopoietic progenitor growth in vitro. J. Infect. Dis. 175 (1997) 1497-1501
13. Murgue B., Roche C., Chungue E., and Deparis X. A prospective study of the duration and magnitude of viremia in children hospitalised during the 1996/1997 dengue-2 outbreak in French Polynesia. J. Med. Virol. 60 (2000) 432-438
14. Murgue B., Cassar O., Deparis X., Guigon M., and Chungue E. Implication of MIP-1α in the inhibition of human hematopoietic progenitor growth by dengue virus. J. Gen. Virol. 79 (1998) 1889-1893
15. Nakao S., Lai C.J., and Young N.S. Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines. Blood 74 (1989) 1235-1240
16. Chungue E., Deparis X., and Murgue B. Dengue in French Polynesia: major features, surveillance, molecular epidemiology and current situation. Public Health Dialog 5 (1998) 154-162
17. World Health Organization, Dengue haemorrhagic fever. Diagnosis, treatment, prevention and control. second ed. (1997), World Health Organization, Geneva
18. Reed L.J., and Muench H.A. A simple method of estimating fifty per cent end points. Am. J. Trop. Med. Hyg. 7 (1983) 493-497
19. Kumar S., Tamura K., Jakobsen I.B., and Nei M. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17 (2001) 1244-1245
20. Peyrefitte C.N., Couissinier-Paris P., Mercier-Perennec V., Bessaud M., Martial J., Kenane N., Durand J.-P.A., and Tolou H.J. Genetic characterization of newly reintroduced dengue virus type 3 in Martinique (French West Indies). J. Clin. Microbiol. 41 (2003) 5195-5198
21. Chungue E., Deubel V., Cassar O., Laille M., and Martin P.M. Molecular epidemiology of dengue 3 viruses and genetic relatedness among dengue 3 strains isolated from patients with mild or severe form of dengue fever in French Polynesia. J. Gen. Virol. 74 (1993) 2765-2770
22. Lanciotti R.S., Lewis J.G., Gubler D.J., and Trent D.W. Molecular evolution and epidemiology of dengue-3 viruses. J. Gen. Virol. 75 (1994) 65-75
23. Wittke V., Robb T.E., Thu H.M., Nisalak A., Nimmannitya S., Kalayanrooj S., Vaughn D.W., Endy T.P., Holmes E.C., and Aaskov J.G. Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period. Virology 301 (2002) 148-156
24. Rico-Hesse R. Microevolution and virulence of dengue viruses. Adv. Virus Res. 59 (2003) 315-341
25. Leitmeyer K.C., Vaughn D.W., Watts D.M., Salas R., Villalobos de Chacon I., Ramos C., and Rico-Hesse R. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73 (1999) 4738-4747
26. Pandey B.D., and Igarashi A. Severity-related differences among nineteen strains of dengue type 2 viruses. Microbiol. Immunol. 44 (2000) 179-188
27. Vorndam V., Mathews J.H., Barrett A.D., Roehrig J.T., and Trent D.W. Molecular and biological characterization of a non-glycosylated isolate of St Louis encephalitis virus. J. Gen. Virol. 74 (1993) 2653-2660
28. Guirakhoo F., Hunt A.R., Lewis J.G., and Roehrig J.T. Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology 194 (1993) 219-223
29. Hurrelbrink R.J., and McMinn P.C. Molecular determinants of virulence: the structural and functional basis for flavivirus attenuation. Adv. Virus Res. 60 (2003) 1-42
30. Lee E., Hall R.A., and Lobigs M. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. J. Virol. 78 (2004) 8271-8280
31. Jacobs M.G., Robinson P.J., Bletchly C., Mackenzie J.M., and Young P.R. Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. FASEB J. 14 (2000) 1603-1610